A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo.
一种新型的、口服生物利用度高的PCSK9小分子抑制剂，具有显著的体内降胆固醇特性
期刊:Journal of Lipid Research
影响因子:4.1
doi:10.1016/j.jlr.2022.100293
Suchowerska Alexandra K, Stokman Geurt, Palmer James T, Coghlan Phillip A, Pieterman Elsbet J, Keijzer Nanda, Lambert Gilles, Chemello Kevin, Jaafar Ali K, Parmar Jasneet, Yan Liping, Tong Yingtao, Mu Lin, Princen Hans M G, Bonnar James, Evison Benny J
